Yahoo Search Busca da Web

Resultado da Busca

  1. Diana Caldwell (22 December 1913 – 3 September 1987) was an English society femme fatale figure who first appeared on the London scene between the wars. She is best known for her part in the murder of Lord Erroll in 1941, dramatised in the 1987 film White Mischief played by Greta Scacchi.

    • Diana Caldwell, 22 December 1913, Hove, Sussex, United Kingdom
    • British
    • 3 September 1987 (aged 73), London
    • Seymour Caldwell and Marjorie (née Howell)
  2. Born Diana Caldwell (19131987), she relocated to the Happy Valley in late 1940, together with her new husband, Sir John "Jock" Delves Broughton, a Baronet with extensive landed estates in England. She almost immediately began a very public affair with the local celebrity Joss Hay, Earl of Erroll.

  3. View Diana Caldwells profile on LinkedIn, a professional community of 1 billion members. Diana Caldwell is the President, CEO and co-founder of Amplified Sciences, a startup life…

    • 500+
    • Amplified Sciences, Inc.
    • North Central High School
    • West Lafayette, Indiana
  4. 1 de nov. de 2021 · Diana Caldwell is president, CEO and co-founder of Amplified Sciences in West Lafayette, Indiana. Prior to founding the company, she was an executive at Eli Lilly and...

    • Purdue Research Foundation
  5. Diana Caldwell, MBA Diana is an accomplished and recognized serial life science entrepreneur with over 25 years of experience in both large corporate and small entrepreneurial environments. Throughout her career, she has successfully driven organizational growth, developed and implemented strategic business plans, raised capital, launched novel life science products, and directed successful teams.

  6. 14 de mar. de 2023 · “Earlier detection, followed by surgical removal, has a much better prognosis,” said Diana Caldwell, Amplified Sciences’ chief executive officer. “We also hope that, with early detection,...

  7. 25 de ago. de 2021 · Diana Caldwell, CEO and president of Amplified Sciences, said the funding will enable validation of the company’s lead assay to detect pancreatic cancer and bring it closer to commercial launch.